RNXT (RenovoRx) Institutional Ownership: 22.55% (As of Jul. 07, 2026)


RNXT RenovoRx Inc RNXT
33 GF Score
Price $0.95
! 2 Warning Signs
View Full Analysis

What is RenovoRx Institutional Ownership?

RenovoRx RNXT +2.99% 33 Institutional Ownership is 22.55% as of Jul. 07, 2026. GuruFocus rates RNXT with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, RenovoRx's institutional ownership is 22.55%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, RenovoRx's Insider Ownership is 2.61%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, RenovoRx's Float Percentage Of Total Shares Outstanding is 96.74%.

RenovoRx Institutional Ownership Historical Data

* Premium members only.

The historical data trend for RenovoRx's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RenovoRx Institutional Ownership Chart

RenovoRx Historical Data

The historical data trend for RenovoRx can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 4.40 4.40 4.40 4.27 4.27 4.27 3.50 3.52 3.52 3.52
RNXT
33GF Score
RenovoRx Inc RNXT
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RenovoRx Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 22.55% mean?
RenovoRx (RNXT) has a Institutional Ownership of 22.55% as of Jul. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on RenovoRx and its competitors.
Is RenovoRx's Institutional Ownership too high?
RenovoRx's current Institutional Ownership is 22.55%. Overall, RenovoRx has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does RenovoRx's Institutional Ownership compare to ACTU and ESLA?
RenovoRx's Institutional Ownership of 22.55% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on RenovoRx and its competitors. RenovoRx's current Institutional Ownership is 22.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RenovoRx stock overvalued right now?
RenovoRx (RNXT) has a current Institutional Ownership of 22.55%. The current Institutional Ownership is 22.55%. RenovoRx's overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For RenovoRx (RNXT), the current Institutional Ownership is 22.55% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RenovoRx Business Description

Address 2570 West El Camino Real, Suite 320, Mountain View, CA, USA, 94040
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
33GF Score

Get the complete analysis for RNXT

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price